DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ativan (Lorazepam) - Published Studies

 
 



Ativan Related Published Studies

Well-designed clinical trials related to Ativan (Lorazepam)

RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): a double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics. [2011.10]

Lorazepam effects on Word Memory Test performance: a randomized, double-blind, placebo-controlled, crossover trial. [2011.07]

Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study. [2011.04]

Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam. [2011.02]

One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI. [2011.01]

RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): a double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics. [2011]

Pharmacodynamic differentiation of lorazepam sleepiness and dizziness using an ordered categorical measure. [2010.08]

Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study. [2010.06]

Use of an acute challenge with d-amphetamine to model cognitive improvement in chronic schizophrenia. [2010.06]

Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge. [2010.05]

Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: a randomized controlled trial. [2010.03]

Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. [2010.02]

A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder. [2010.02]

Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. [2010]

The effects of lorazepam on extrastriatal dopamine D(2/3)-receptors-A double-blind randomized placebo-controlled PET study. [2009.11.30]

The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers. [2009.08]

A randomized, double-blind comparison of lorazepam and chlordiazepoxide in patients with uncomplicated alcohol withdrawal. [2009.05]

Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: A randomized controlled trial. [2009.03.16]

The apolipoprotein E epsilon4 allele and memory performance in HIV-1 seropositive subjects: differences at baseline but not after acute oral lorazepam challenge. [2008.11]

Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation. [2008.03]

Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation. [2008.01.02]

Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea/vomiting: results of two pilot trials. [2008.01]

Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. [2007.12.12]

Propofol associated with a shorter duration of mechanical ventilation than scheduled intermittent lorazepam: a database analysis using Project IMPACT. [2007.12]

Effects of lorazepam on deductive reasoning. [2007.11]

Lorazepam induces multiple disturbances in selective attention: attentional overload, decrement in target processing efficiency, and shifts in perceptual discrimination and response bias. [2007.09]

Efficacy and Tolerability of a Standardized Herbal Product from Galphimia glauca on Generalized Anxiety Disorder. A Randomized, Double-Blind Clinical Trial Controlled with Lorazepam. [2007.07]

Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes. [2007.06]

Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers. [2007.06]

Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin. [2007.02.15]

A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteers. [2007.01]

Lorazepam dose-dependently decreases risk-taking related activation in limbic areas. [2006.11]

Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine. [2006.11]

Effects of the amnesic drug lorazepam on complete and partial information retrieval and monitoring accuracy. [2006.11]

GABAergic modulation of diffuse noxious inhibitory controls (DNIC): a test by use of lorazepam. [2006.11]

Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial. [2006.05.13]

A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients. [2006.05]

Dose-dependent retrograde facilitation of verbal memory in healthy elderly after acute oral lorazepam administration. [2006.05]

Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice. [2006.04]

Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial. [2006.03]

Some facilitatory effects of lorazepam on dynamic visual binding. [2006.01]

Drugs, memory, and metamemory: a dose-effect study with lorazepam and scopolamine. [2005.11]

Gender differences in response to lorazepam in a human drug discrimination study. [2005.11]

Effects of lorazepam on fear-potentiated startle responses in man. [2005.05]

Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. [2005.04.15]

Anterior limbic alpha-like activity: a low resolution electromagnetic tomography study with lorazepam challenge. [2005.04]

Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing. [2005.03]

Specific effects of an amnesic drug: effect of lorazepam on study time allocation and on judgment of learning. [2005.01]

Well-designed clinical trials possibly related to Ativan (Lorazepam)

Intramuscular versus intravenous therapy for prehospital status epilepticus. [2012]

Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine. [2012]

treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial. [2011.10]

Prophylactic analgesia before percutaneous liver biopsy: a clinical comparative study. [2011.09]

Intrauterine lidocaine infusion for pain management during outpatient transcervical tubal sterilization: a randomized controlled trial. [2011.08.17]

Benefit effect of naloxone in benzodiazepines intoxication: findings of a preliminary study. [2011.07]

A prospective, randomized, trial of phenobarbital versus benzodiazepines for acute alcohol withdrawal. [2011.05]

Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine. [2011.01]

Procalcitonin and C-reactive protein levels at admission as predictors of duration of acute brain dysfunction in critically ill patients. [2011]

Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial. [2011]

Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine. [2011]

Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study. [2010.06]

The complex interplay between delirium, sepsis and sedation. [2010]

Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in The Netherlands. [2010]

Psychometric evaluation of a visual analog scale for the assessment of anxiety. [2010]

Effect of hypnotic drugs on body balance and standing steadiness. [2010]

An electronic regulatory document management system for a clinical trial network. [2010]

Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder. [2010]

Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients. [2009.11]

Benzodiazepines for delirium. [2009.10.07]

Effects of pregabalin on post operative morphine consumption and pain after abdominal hysterectomy with/without salphingo-oophorectomy: a randomized, double-blind trial. [2009.10]

Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients. [2009.07.09]

Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery--a randomized controlled trial. [2009.05]

Differing effects of intracortical circuits on plasticity. [2009.03]

Oral compared with intravenous sedation for first-trimester surgical abortion: a randomized controlled trial. [2009.02]

Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands. [2009.02]

Benzodiazepines for delirium. [2009.01.21]

Clinical evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A): a new instrument to assess the onset of symptomatic improvement in generalized anxiety disorder. [2009.01]

Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia. [2008.12]

Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. [2008.07.16]

A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. [2008.06]

Effect of pharmacological treatment on temperament and character in panic disorder. [2008.03.15]

Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. [2008.03]

Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. [2007.10]

Review: Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. [2007.09]

The role of sedation tests in identifying sedative drug effects in healthy volunteers and their power to dissociate sedative-related impairments from memory dysfunctions. [2007.08]

A randomized trial comparing local intracervical and combined local and paracervical anesthesia in outpatient hysteroscopy. [2007.03]

Effects of gamma-aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia. [2007.02]

Role of lormetazepam in the treatment of insomnia in the elderly. [2007]

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. [2006.07]

Sedation and memory: studies with a histamine H-1 receptor antagonist. [2006.07]

Scopolamine induces impairments in the recognition of human facial expressions of anger and disgust. [2006.05]

Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies. [2006.01]

Alcohol withdrawal pharmacotherapy for inpatients with medical comorbidity. [2006]

Profiling the subjective, psychomotor, and physiological effects of tramadol in recreational drug users. [2005.11.01]

Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring. [2005.10]

Double-blind study of cyamemazine and diazepam in the alcohol withdrawal syndrome. [2005.10]

Morphine, gabapentin, or their combination for neuropathic pain. [2005.03.31]

Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder. [2005.03]

Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial. [2005.01]

Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. [2005.01]

Other research related to Ativan (Lorazepam)

Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study. [2012]

Pharmacokinetics of buccal and intranasal lorazepam in healthy adult volunteers. [2012]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012